The role of C5AR2 in properly controlling C5a is considerable; otherwise, excessive or unresolved C5a production can aggravate a plethora of acute and chronic diseases, such as ischemia-reperfusion injury, rheumatic arthritis, sepsis atherosclerosis, and cancer, even COVID-19 (10–13). This evidence concerns the gene C5AR2 and cancer.